Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.6.2 was added and v3.6.0 was removed. This indicates a page update or maintenance rather than any new or altered study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedNew help/navigation sections were added: How to Read a Study Record, Common Questions, and How to Join a Study. A recruitment status note indicates enrollment is closed ('No longer looking for participants'), and a site revision (Revision: v3.6.0) was added.SummaryDifference0.3%

- Check26 days agoChange DetectedRevision: v3.5.5 has been added to indicate the latest update to the page content. The previous revision, v3.5.4, has been removed.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 on the page, indicating a new release of the content. The change appears to be a minor, non-user-facing maintenance update and does not modify the study information or core functionality presented to users.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, representing a small update to the page metadata. No substantive study information appears to have changed.SummaryDifference0.0%

- Check76 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2; no visible changes to the study details are apparent.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.